[EN below] 📢Ekscytujące wieści! Z dumą ogłaszamy, że SyVento BioTech jest w centrum uwagi! W serwisie Wyborcza.pl ukazał się artykuł na temat naszych innowacyjnych osiągnięć w dziedzinie biotechnologii oraz nowoczesnej fabryki, którą otworzyliśmy w Skawinie. Dzięki imponującej inwestycji, wynoszącej 100 milionów dolarów, staliśmy się liderem rozwoju biotechnologii w Polsce, co nie umknęło uwadze mediów. W SyVento specjalizujemy się w rozwoju i produkcji szczepionek oraz produktów terapeutycznych z wykorzystaniem przełomowej technologii mRNA. Wraz z nowo uruchomioną linią produkcyjną, o mocy przerobowej 36 mln dawek szczepionek rocznie, jesteśmy jednym z najnowocześniejszych centrów biotechnologicznych na świecie - jedynym na skalę kraju i Europy. Aby dowiedzieć się więcej i poznać naszą wizję na przyszłość, zachęcamy do zapoznania się z pełnym artykułem: https://lnkd.in/d_mYMjaP EN: 📢Exciting news! We are proud to announce that SyVento BioTech is in the spotlight! An article has appeared on Wyborcza.pl highlighting our innovative achievements in biotechnology and the modern facility we opened in Skawina. With an impressive investment of $100 million, we have become a leader in biotech development in Poland, a fact that has not gone unnoticed by the media. At SyVento, we specialize in the development and production of vaccines and therapeutic products using groundbreaking mRNA technology. Along with our newly launched production line, with a capacity of 36 million vaccine doses per year, we are one of the most advanced biotechnology centers in the world—unique in the country and Europe. To learn more and discover our vision for the future, check out the full article: https://lnkd.in/d_mYMjaP #SyVento #Biotechnology #mRNA #Innovation #PressRelease
SyVento BioTech
Badania w zakresie biotechnologii
Skawina, Małopolskie 1933 obserwujących
Encapsulating your ideas
Informacje
SyVento BioTech is a biotechnology company offering comprehensive services in the development of lipid-based nanocarriers and LNP technology. We specialize in the development of lipid-based formulations for pharmaceutical products, including RNA-based drug products. Our unique in a global scale end-to-end service gives the opportunity to design and implement projects to encapsulate and deliver therapeutic molecules such as small molecules, RNA, DNA, and proteins to targeted cells or tissues. Our expertise includes the development of liposomal formulations, RNA synthesis, and finally cGMP production in our state-of-the-art facility, along with support services at all levels of product development. Thanks to many years of experience in the development of liposomal carriers, our R&D Team guarantees that each project will be delivered successfully.
- Witryna
-
www.syvento.com
Link zewnętrzny organizacji SyVento BioTech
- Branża
- Badania w zakresie biotechnologii
- Wielkość firmy
- 11–50 pracowników
- Siedziba główna
- Skawina, Małopolskie
- Rodzaj
- Spółka prywatna
Lokalizacje
-
Główna
Otrzymaj wskazówki o trasie dojazdu
Za Górą
19
Skawina, Małopolskie 32-050, PL
Pracownicy SyVento BioTech
Aktualizacje
-
SyVento BioTech exploring Swedish Innovation. We're attending #BioEurope2024 Stockholm, the premier partnering event in life sciences. Our delegate Maciej Boruczkowski, will be exploring the impact of the Swedish approach to the latest trends, in the BioTech industry. Join us in Stockholm, and discover how SyVento BioTech is contributing to the future of life sciences. #BioEurope #Stockholm #LifeSciences #Innovation #SyVentoBioTech
-
-
SyVento BioTech is heading to Bio Europe Stockholm! Maciej Boruczkowski from our team will be exploring the Swedish approach to innovation and connecting with potential partners. Stay tuned for updates! #BioEurope #Stockholm #LifeSciences #Innovation #SyVentoBioTech
-
-
Here we are in Milan! Please vist #SyVento Team at #Booth24A10 to talk about LNP, mRNA, aseptic clinical F&F and other collaboration scope related to lipid nanocarriers Our experts are waiting for you!
-
-
Visit us at #Booth24A10 and learn how we can support your lipid nanoparticles delivery projects and clinical aseptic fill and finish. Additionally, we will be able to strengthen you thanks to #eatyx - full-value meals providing the ideal amount of macro and micro nutrients. #CPHI #Booth24A10 #SyVento #eatyx
-
-
Meet us next week at BioJapan! SyVento BioTech is excited to participate in Asia's largest life science partnering event. Discover our innovative platforms in the advanced mRNA synthesis, development of LNP and liposomal formulations and batches, and how we can assist you on your product development. Connect with our team Eliza Milewicz and Maciej Boruczkowski in situ! #BioJapan #LifeScience #Innovation
-
-
We're thrilled to showcase our LNP production expertise at CPHI Milan. Visit us at #Booth24A10! Our team of experts is eager to connect and discuss your clinical trial needs. https://lnkd.in/efSkkWvY #CPHIMilan #TeamSyVentoBioTech #Pharma #LNP #Biotech
-
Join our CTO Dominik Lipka PhD Eng. at Cytiva's 𝗥𝗡𝗔-𝗟𝗡𝗣 𝗩𝗶𝗿𝘁𝘂𝗮𝗹 𝗦𝘂𝗺𝗺𝗶𝘁!🧬 Discover the latest breakthroughs in mRNA-LNP technology and its applications in vaccine development and cell and gene therapies. Register now to join us on this exclusive online event! https://lnkd.in/exkHRDQG #RNA #LNP #Biotechnology #Pharma
-
-
𝗚𝗲𝘁 𝗿𝗲𝗮𝗱𝘆 𝘁𝗼 𝗰𝗼𝗻𝗻𝗲𝗰𝘁 𝘄𝗶𝘁𝗵 𝗦𝘆𝗩𝗲𝗻𝘁𝗼 𝗕𝗶𝗼𝗧𝗲𝗰𝗵 𝗮𝘁 𝗖𝗣𝗛𝗜 𝗠𝗶𝗹𝗮𝗻! 🌍 Come to booth #24A10 and meet part of the brilliant team behind SyVento BioTech! We will be presenting our production and aseptic fill and finish services and our single-use system (SUS). Want to book a meeting with our team? Drop us an email now! sales@syvento.com https://lnkd.in/efSkkWvY #CPHIMilan #TeamSyVentoBioTech #Pharma #LNP #Biotech
-